Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012:2012:361534.
doi: 10.1155/2012/361534. Epub 2012 Apr 22.

Hyaluronan Does Not Affect Bupivacaine's Inhibitory Action on Voltage-Gated Potassium Channel Activities in Bovine Articular Chondrocytes

Affiliations

Hyaluronan Does Not Affect Bupivacaine's Inhibitory Action on Voltage-Gated Potassium Channel Activities in Bovine Articular Chondrocytes

William Hester et al. Adv Orthop. 2012.

Abstract

Objectives. The objective of this paper is to determine if hyaluronan affects bupivacaine's anesthetic function. Methods. Whole cell patch clamp recordings were performed on bovine articular chondrocytes cultured in 60 mm dishes. The chondrocytes were treated with phosphate-buffered saline (control group), 7.5 mg/mL hyaluronan (Orthovisc), 0.25% bupivacaine, or a mixture of 7.5 mg/mL hyaluronan and 0.25% bupivacaine. Outward currents were elicited by step depolarization from -90 mV to 150 mV with 5 mV increments and holding for 200 ms. Results. The amplitude of outward currents elicited at 150 mV was 607.1 ± 135.4 pA (mean ± standard error) in the chondrocytes treated with phosphate buffered saline, 550.0 ± 194.9 pA in the chondrocytes treated with hyaluronan, 18.4 ± 8.3 pA in the chondrocytes treated with bupivacaine, and 12.8 ± 2.6 pA in the chondrocytes treated with a mixture of hyaluronan and bupivacaine. Conclusion. Hyaluronan does not affect bupivacaine's inhibitory action on the potassium channel activities in bovine articular chondrocytes. This finding suggests that intra-articular injection of a mixture of hyaluronan and bupivacaine may not affect the anesthetic effects of bupivacaine.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Representative whole cell patch clamp recordings showing outward currents elicited by step depolarization from −90 mV to 150 mV with 5 mV increments and holding for 200 ms. Bovine articular chondrocytes were treated with PBS (a), 7.5 mg/mL hyaluronan (b), 0.25% bupivacaine (c), and a mixture of 7.5 mg/mL hyaluronan and 0.25% bupivacaine (d).
Figure 2
Figure 2
Representative whole cell patch clamp recordings showing outward currents elicited by depolarization at 150 mV with holding for 200 ms. Bovine articular chondrocytes were treated with PBS (a), 7.5 mg/mL hyaluronan (b), 0.25% bupivacaine (c), and a mixture of 7.5 mg/mL hyaluronan and 0.25% bupivacaine (d). (e) Means and standard errors (error bars) of the outward currents recorded in five chondrocytes (n = 5). P values were obtained by Student's t-test (two-tailed).
Figure 3
Figure 3
Representative whole cell patch clamp recordings showing outward currents elicited at 150 mV with holding for 200 ms. Bovine articular chondrocytes were treated with PBS (a), 0.25% bupivacaine for 5 minutes (b), 0.25% bupivacaine for 10 minutes (c), and cesium (potassium channel blocker) (d).

References

    1. Allen GC, Amand MAS, Lui ACP, Johnson DH, Lindsay MP. Postarthroscopy analgesia with intraarticular bupivacaine/morphine: a randomized clinical trial. Anesthesiology. 1993;79(3):475–480. - PubMed
    1. Scholz A. Mechanisms of (local) anaesthetics on voltage-gated sodium and other ion channels. British Journal of Anaesthesia. 2002;89(1):52–61. - PubMed
    1. Courtney KR, Kendig JJ. Bupivacaine is an effective potassium channel blocker in heart. Biochimica et Biophysica Acta—Biomembranes. 1988;939(1):163–166. - PubMed
    1. Li X, Shah A, Franklin P, Merolli R, Bradley J, Busconi B. Arthroscopic debridement of the osteoarthritic knee combined with hyaluronic acid (Orthovisc) treatment: a case series and review of the literature. Journal of Orthopaedic Surgery and Research. 2008;3(1, article no. 43) - PMC - PubMed
    1. Gomis A, Pawlak M, Balazs EA, Schmidt RF, Belmonte C. Effects of different molecular weight elastoviscous hyaluronan solutions on articular nociceptive afferents. Arthritis and Rheumatism. 2004;50(1):314–326. - PubMed

LinkOut - more resources